iX Biopharma Ltd. announced that resignation of Mr. Yee Chia Hsing as Director of Corporate Affairs and General Manager of Entity Health Ltd. Reason For Cessation: Mr. Yee Chia Hsing has tendered his resignation with the Company to pursue other career opportunities. To provide continuity, his responsibilities will be taken over by the Company's Chief Commercial Officer, Ms. Eva Tan. Based on its enquiries, the Sponsor is satisfied that, save as disclosed in this announcement, there are no other material reasons for Mr. Yee's cessation as Director of Corporate Affairs and General Manager of Entity Health Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.039 SGD | -2.50% | 0.00% | -13.33% |
03-12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
03-12 | IX Biopharma Introduces New Sublingual Wafer | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.33% | 22.2M | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 42C Stock
- News iX Biopharma Ltd.
- IX Biopharma Ltd. Announces Cessation of Yee Chia Hsing as Director of Corporate Affairs & General Manager of Entity Health Ltd